@HarvardTechXfer

Harvard's Office of Technology Development helps university research grow into life-changing innovations.

 Cambridge, MA
otd.harvard.edu/
Joined September 2010
  • Tweets1.5K
  • Following285
  • Followers3.4K
240Media
Read more about all four @HarvardSalata @HarvardTechXfer translational fund awards here: salatainstitute.harvard.edu/…

Four Harvard research teams receive translational funding to advance climate change tech - The...

With funding and support from the Climate and Sustainability Translational Fund, researchers will pursue green jet fuel, cleaner chemicals, sustainable packaging, and carbon storage.

salatainstitute.harvard.edu
1
1
1
239
Harvard OTD retweeted
DBMI at Harvard Med
@HarvardDBMI16 May 2024
Tuesday 5/28/24: Biomedical Informatics Entrepreneurs Salon #BIES hosted by @zakkohane w/ @HarvardTechXfer 🍕🥤🍪 4:30pm In-person food/drink/network at HMS 🗣️🧠💡5:00–6:00pm (Zoom option) Robert Plenge, @rplenge @bmsnews Bristol Myers Squibb Register: eventbrite.com/e/bies-robert…
7
2
11
7,099
Thank you @doescience @ENERGY for highlighting our recent work by @LimGarrick @SelinaKKaiser1 on @NatureCatalysis! @hseas @HarvardCCB @wyssinstitute @HarvardTechXfer @HarvardResearch
DOE Office of Science@doescience1 Mar 2024
90% of the processes in the chemical industry - including pharmaceuticals - depend on catalysts. Inspired by the structure of butterfly wings, researchers @Harvard designed a new form of catalyst that could result in more efficient & selective reactions: seas.harvard.edu/news/2024/0…
Image of two gold and silver colored nanoparticles made of clusters of spheres on top of other networks of white and salmon colored spheres

ALT Image of two gold and silver colored nanoparticles made of clusters of spheres on top of other networks of white and salmon colored spheres

2
4
22
4,976
The second-most-popular story of 2023 was about @GametoGen licensing our technology for growing ovaroids from Harvard. They hope to use this for new treatments for infertility and other women's reproductive health conditions. @HarvardTechXfer wyss.harvard.edu/news/gameto…

Gameto licenses Wyss Institute’s technology for growing human ovaries from Harvard University

By Lindsay Brownell (BOSTON) — Despite the fact that we all start out as an egg cell in one of our mother’s ovaries, these human reproductive organs are surprisingly under-studied. Scientists have...

wyss.harvard.edu
1
1
6
1,315
Harvard OTD retweeted
DBMI at Harvard Med
@HarvardDBMI9 Jan 2024
Wednesday 1/17/24: Biomedical Informatics Entrepreneurs Salon #BIES 🍕🥤🍪 4:30pm In-person food/drink/network at HMS 🗣️🧠💡 5:00–6:00pm (Zoom option) Molly Gibson @gibsmk of @generate_biomed/@FlagshipPioneer Register: bit.ly/biesJan2024
1
3
2
11
2,894
Harvard OTD retweeted
DBMI at Harvard Med
@HarvardDBMI11 Dec 2023
Tomorrow 5pm featuring @TakedaPharma's Anne Heatherington Register: bit.ly/bies1212

Biomedical Informatics Entrepreneurs Salon: Anne Heatherington, Takeda

A monthly conversation about medicine, biology, computers, and entrepreneurship.

eventbrite.com
DBMI at Harvard Med
@HarvardDBMI5 Dec 2023
Join us a week from today 12/12/23: Biomedical Informatics Entrepreneurs Salon #BIES hosted by @zakkohane w/@HarvardTechXfer 🍕🥤🍪 5:00pm In-person food/drink/network at HMS 🗣️🧠💡5:30–6:30pm (Zoom option) @TakedaPharma's Anne Heatherington Register: bit.ly/bies1212
Anne Heatherington is Senior Vice President and Head of Data Sciences Institute (DSI) with Research and Development (R&D) at Takeda Pharmaceuticals. She oversees many of the quantitative groups within Takeda, including Statistics and Quantitative Solutions, Global Evidence and Outcomes, Quantitative Clinical Pharmacology, Data Architecture and Digital Solutions and Digital Strategy Group. Her mandate is to drive innovation and excellence in R&D through focusing on knowledge through data, enabling patient-centricity and developing tools and infrastructure to understand the safety and efficacy of Takeda's medicines. Anne has over 20 years' experience leading organizations and programs in large pharma, mid-size biotechs and start-up organizations, including Summit Therapeutics, Pfizer Ltd and Amgen Inc. Anne's PhD in pharmacokinetics is from the University of Manchester, England. She completed post-doctoral training in the Centre for Bioengineering at University of Washington, Seattle.

ALT Anne Heatherington is Senior Vice President and Head of Data Sciences Institute (DSI) with Research and Development (R&D) at Takeda Pharmaceuticals. She oversees many of the quantitative groups within Takeda, including Statistics and Quantitative Solutions, Global Evidence and Outcomes, Quantitative Clinical Pharmacology, Data Architecture and Digital Solutions and Digital Strategy Group. Her mandate is to drive innovation and excellence in R&D through focusing on knowledge through data, enabling patient-centricity and developing tools and infrastructure to understand the safety and efficacy of Takeda's medicines. Anne has over 20 years' experience leading organizations and programs in large pharma, mid-size biotechs and start-up organizations, including Summit Therapeutics, Pfizer Ltd and Amgen Inc. Anne's PhD in pharmacokinetics is from the University of Manchester, England. She completed post-doctoral training in the Centre for Bioengineering at University of Washington, Seattle.

1
2
1
5
2,373
Marco Jost, HMS assistant professor of microbiology at the Blavatnik Institute, describes the relationship between gut microbes and the human body as a chemical dialog bit.ly/3FHw6Lp

Confronting the Mystery of the Microbiome

Marco Jost works to decode the cross talk between microbes and their human hosts

hms.harvard.edu
6
11
41
16,416
Scientists have grown an “ovaroid,” an assembly of cells designed to mimic the follicle of a human ovary. It's a huge step toward developing a suite of biotechnologies that could make the previously impossible possible in baby-making, @GraceRubie writes. trib.al/JXhQyYz

The next frontier in baby-making - The Boston Globe

More successful IVF, egg cells from men, and sperm cells from women? Biotech researchers aim to greatly expand reproductive opportunity.

bostonglobe.com
6
6
2,092
📢 The next Biomedical Informatics Entrepreneurs Salon hosted by @HarvardTechXfer + @HarvardDBMI will feature HDSI Faculty Affiliate Bill Lotter, assistant professor at @DanaFarber + @harvardmed: eventbrite.com/e/bies-bill-l… 🗓 Wednesday, September 27 ⏰ 4:30 PM EST 📍 Zoom

BIES: Bill Lotter, Dana-Farber Cancer Institute and Harvard Medical School

A monthly conversation about medicine, biology, computers, and entrepreneurship.

eventbrite.com
4
10
1,499
🔊Breaking News: Metalenz partners with UMC to mass produce its metasurface optics as direct supplier to OEMs. rb.gy/6l9g7 #disruptivetech #machinevision #3Dsensing #supplychain #metasurfaces #openmarket $UMC
1
25
1
11
1,863
Celebrating women engineers — past, present & future 🌟
6
46
3,915
Harvard OTD retweeted
Harvard SEAS@hseas13 Jun 2023
Lidiya Mishchenko learned about tech commercialization during her applied physics Ph.D. studies in @AizenbergLab and work at @HarvardTechXfer. She went on to earn a law degree at @gwlaw, become a district and federal circuit clerk, and teach at @DukeLaw. buff.ly/3J7cphS
Photo of Lidiya Mishchenko, S.M. ’09, Ph.D. ’12

ALT Photo of Lidiya Mishchenko, S.M. ’09, Ph.D. ’12

4
2
21
4,114
Excited to see our lab’s work being translated by @TrestleBio! Grateful to @wyssinstitute and @HarvardTechXfer for their invaluable support 🙏
Wyss Institute@wyssinstitute6 Jun 2023
In the US alone, ~100,000 patients are waiting for a kidney transplant. @TrestleBio licensed a suite of technologies developed in the @JenniferALewis1 lab to advance the creation of implantable vascularized and functional kidney tissue. #WorldTransplantDay wyss.harvard.edu/technology/…

Kidney Engineering Technology for New Tissue Replacement Therapies

Trestle Biotherapeutics licensed 3D bioprinting, and stem cell and kidney organoid engineering methods to help it create kidney repair and replacement therapies. These could become new standard-of-...

wyss.harvard.edu
1
16
1,650
It’s day 3 of #HarvardClimateActionWeek – joining virtually? Stream the @HarvardHBS Accelerating Climate Solutions event from 8:30AM - 6PM ET: bit.ly/3nEpJ5Q From 11AM – 12:30PM ET stream the @hgse Building Our Resilient Future event here: bit.ly/3HYME33
2
5
8
6,287
Today, hundreds of leaders from government, business, academia, and civil society gathered at @Harvard University and online for the first annual Harvard Climate Symposium.
An audience in an auditorium watches a panel session. Larry Bacow is seated on stage. Behind him on a large screen, John Kerry is seen. The screen reads "Harvard Climate Symposium: Strengthening Global Ambition"

ALT An audience in an auditorium watches a panel session. Larry Bacow is seated on stage. Behind him on a large screen, John Kerry is seen. The screen reads "Harvard Climate Symposium: Strengthening Global Ambition"

An audience member stands holding a microphone to ask a question.

ALT An audience member stands holding a microphone to ask a question.

Four panelists are seated on stage. A coffee table in front of them holds glasses of water. They are looking at the moderator.

ALT Four panelists are seated on stage. A coffee table in front of them holds glasses of water. They are looking at the moderator.

A group of four people seated on stone benches outside speak to each other. Other people are walking in the background near trees.

ALT A group of four people seated on stone benches outside speak to each other. Other people are walking in the background near trees.

4
9
1
41
14,795
Northpond Labs funds third Wyss Institute research project, this time to accelerate highly effective DNA nanotechnology-driven drug discovery. @npv_vc #DrugDiscovery wyss.harvard.edu/news/wyss-i…

Northpond supports third Wyss Institute research project

By Benjamin Boettner (BOSTON) – The Wyss Institute for Biologically Inspired Engineering at Harvard University, Boston Children’s Hospital, and Northpond Labs, the research-and-development affiliate...

wyss.harvard.edu
3
3
8
7,065
Impressive as they’ve been in the lab, the use of #metasurfaces in commercial devices has always seemed just out of reach. Now, @MetalenzNews—a company spun out of the research group of Federico Capasso (@quantumcascade)—says it has crossed that threshold. ow.ly/pLGL50JCVuG
2
2
6
The Salata Institute for Climate and Sustainability will launch in the fall of 2022 with a mission to develop and promote durable, effective, and equitable solutions to climate-change hrvd.me/ClimateGift1234t

$200M gift to fund Harvard climate crisis institute

Gift from Melanie and Jean Salata to fund Salata Institute for Climate and Sustainability.

news.harvard.edu
2
16
1
48
On June 14, Harvard Public Health magazine will bring together founders & investors to talk about the challenges—and rewards—of developing goods & services aimed at improving public health. Register to join @Vir_Biotech @rowe @MarianaMatusG and more: bit.ly/3Nx74AP
From idea to impact: The new market for public health entrepreneurs June 14 @ 1:00 pm - 2:00 pm Hosted by Harvard Public Health Magazine hsph.me/ideas-to-impact

ALT From idea to impact: The new market for public health entrepreneurs June 14 @ 1:00 pm - 2:00 pm Hosted by Harvard Public Health Magazine hsph.me/ideas-to-impact

7
2
11
Metasurfaces enter the high volume smart phone and sensor markets! Kudos to Harvard startup Metalenz, CEO Rob Devlin and to my group for the foundational Science & Invention leading to a high volume product in record time! I am proud! forbes.com/sites/johnkoetsie…
5
12
2
100
Load more